|
|
||||||||
1 Department of Physiology, Free University of Brussels, B1070 Brussels, Belgium; 2 Faculty of Health Sciences, University of Copenhagen, DK-2000 Copenhagen N, Denmark; 3 Department of Intensive Care Medicine, Erasme Hôspital, B1070 Brussels, Belgium; 4 National Center for Cardiology and Internal Medicine, Bishkek, Kyrgyzstan; 5 Department of Medical Physics, Royal Hallamshire Hospital, Sheffield S10 2JF, United Kingdom
| |
ABSTRACT |
|---|
|
|
|---|
Recent work suggests that
treatment with inhaled
2-agonists reduces the incidence
of high-altitude pulmonary edema in susceptible subjects by increasing
respiratory epithelial sodium transport. We estimated respiratory
epithelial ion transport by transepithelial nasal potential difference
(NPD) measurements in 20 normal male subjects before, during, and after
a stay at 3,800 m. NPD hyperpolarized on ascent to 3,800 m
(P < 0.05), but the change in potential difference with superperfusion of amiloride or isoprenaline was unaffected. Vital
capacity (VC) fell on ascent to 3,800 m (P < 0.05), as
did the normalized change in electrical impedance (NCI) measured over the right lung parenchyma (P < 0.05) suggestive of an
increase in extravascular lung water. Echo-Doppler-estimated pulmonary artery pressure increases were insufficient to cause clinical pulmonary
edema. There was a positive correlation between VC and NCI
(R2 = 0.633) and between NPD and both VC
and NCI (R2 = 0.267 and 0.418). These
changes suggest that altered respiratory epithelial ion transport might
play a role in the development of subclinical pulmonary edema at high
altitude in normal subjects.
pulmonary edema; hypobaric hypoxia
| |
INTRODUCTION |
|---|
|
|
|---|
ALTHOUGH ONLY A MINORITY
OF those who go to high altitude develop the potentially fatal
condition of high-altitude pulmonary edema (HAPE), there is increasing
evidence that the majority of people ascending to altitude may develop
subclinical pulmonary edema (9). Forced vital capacity
(FVC) falls on ascent to high altitude and is thought to be primarily
due to subclinical pulmonary edema (32). The control of
pulmonary extravascular lung water (EVLW) has traditionally been
attributed to the interplay of Starling forces, with the pulmonary
capillary pressure attributed the major regulatory role. It is now
realized that sodium transport across the respiratory epithelium plays
an important role in the removal of alveolar water
(34) and that an intact epithelial barrier is necessary
for the resolution of alveolar edema (35). Hypoxia reduces
epithelial sodium transport in cultured rat alveolar epithelial monolayers (29) and decreases the expression of alveolar
epithelial ion transport proteins (8). In addition,
treatment of HAPE-susceptible individuals with inhaled
2-agonists, which are known to increase transepithelial
sodium transport, decreases pulmonary edema without any effect on
pulmonary hemodynamics (44).
Measurement of alveolar ion transport in vivo in human subjects is not feasible; however, measurement of the potential difference (PD) generated by ion transport in the nasal mucosa can be used as a marker of transport in the distal respiratory epithelium (22, 23). By perfusing the nasal mucosa with substances that alter the conductance of specific ion channels, the relative contribution of these channels to the PD may be estimated (21). Amiloride inhibits the amiloride-sensitive epithelial sodium channel (ENaC), whereas a low-concentration chloride solution containing isoprenaline can be used to stimulate chloride secretion, predominantly via the cystic fibrosis transmembrane regulator. Assessing changes in lung water at high altitude has presented problems because of the difficulty in detecting early changes in EVLW. The Sheffield electrical impedance tomography (EIT) system is a portable device that measures the change in electrical resistivity of lung tissue occurring in the presence of EVLW to give a cross-sectional image of the resistive changes in a tissue plane (5).
We therefore measured nasal potential difference (NPD), FVC, EIT changes, and pulmonary circulation pressures by Doppler echocardiography in a group of normal male volunteers before, during, and after a 2-wk stay at 3,800 m in the Tien Shan mountains of Kyrgyzstan.
| |
METHODS |
|---|
|
|
|---|
Subjects.
Twenty male Kyrgyz lowlander volunteers (age range 18-35 yr) with no previous exposure to high altitude underwent baseline tests (BL) in Bishkek (altitude 700 m) before being transported by road in 7 h to Kumtor gold mine at an altitude of 3,800 m. High-altitude measurements were repeated on days 1, 2, 5, and 10 for all subjects, on day 14 for half of the subjects, and day 15 for the remaining half (HA01, HA02, HA05, HA10, and HA14/15, respectively). Subjects returned to Bishkek by road, and return to baseline (RBL) measurements were made within 24 h of their departure from high altitude. All subjects gave written, informed consent, and the project was approved by the ethics committee of the Faculty of Medicine of the Free University of Brussels.Transepithelial NPD.
Transepithelial NPD was measured using a 5-French umbilical catheter
(Tyco Healthcare, Tullamore, Ireland) as the exploring bridge. The
reference bridge was a 20-gauge catheter inserted into a forearm vein
and perfused with 0.9% NaCl solution. The bridges were connected by
Driref KCl electrodes (World Precision Instruments, Sarasota, Florida)
to a high-impedance voltmeter (M-4640A, Metex, Seoul, Korea) The output
from the voltmeter was recorded onto a personal computer using software
supplied with the meter. The nasal catheter was perfused consecutively
at a rate of ~0.5 ml/min with solutions of 1) 154 mM
sodium chloride, 2) 154 mM sodium chloride with
10
4 M amiloride hydrochloride to assess the
amiloride-inhibitable sodium current, and 3) 134 mM sodium
gluconate and 5 mM sodium chloride containing 10
4 M
amiloride hydrochloride and 10
5 M isoprenaline
hydrochloride to stimulate chloride secretion. Each solution was
perfused until the voltage had reached a stable plateau lasting for at
least 6 s. Measurements were always made at the same distance into
the same nostril. Technical problems have been reported because of the
nasal drying and crusting that occurs at high altitude
(30). To avoid this, subjects bathed the test nostril with
10 ml of 0.9% sodium chloride solution morning and evening throughout
the study. The liquid junction potential was calculated for the
solutions used, and the measured results were corrected accordingly
(2). In this article, a potential that becomes more
negative is said to hyperpolarize, whereas a potential that becomes
less negative is said to depolarize. Because of a technical problem
with the electrodes, no recordings were obtained at RBL.
EIT. EIT measurements were performed by use of the Mark 1 DAS-01P Sheffield Applied Potential Tomograph (Department of Medical Physics, Royal Hallamshire Hospital, Sheffield, UK). For each measurement, 16 silver-silver chloride ECG electrodes (Kendall, Neustadt/Donau, Germany) were placed horizontally, equidistant around the thorax at the height of the xiphisternum. Pairs of electrodes were stimulated with an alternating current at a frequency of 51 kHz, and recordings were made by the remaining electrodes. This process was then repeated consecutively with the measurement module making a set of transfer impedance measurements at 25 frames/s. With the subject seated, measurements made at total lung capacity (TLC) were compared with a reference measurement made at residual volume (RV). From these paired measurements, cross-sectional images of the changes in impedance from RV to TLC were generated (5, 6). The change in impedance between RV and TLC was calculated with an analysis program written using MATLAB software (The MathWorks, Natick, MA), which permits a zone of interest to be delineated. The zone chosen was over the parenchyma of the right lung to avoid interference from changes in cardiac volume with respiration, and excluding the chest wall. Results represent the fractional increase in impedance on inspiration from RV to TLC with the presence of EVLW suggested by a smaller fractional increase. The fractional impedance changes were normalized to correct for changes in lung volume by dividing by FVC and are expressed as the fractional change per liter of FVC. Measurements were repeated three times, and results given are the mean of each group of three measurements. After the first set of recordings at BL, the positions of the electrodes were marked with an indelible marker pen; these marks were renewed daily so that subsequent recordings were made with the electrodes in an identical position.
FVC. FVC was measured by use of a Micro Medical MicroPlus Spirometer (Micro Medical, Rochester, Kent, UK). Measurements were made in accordance with the guidelines of the British Thoracic Society (4). The best of three blows were recorded. All volumes are given at body temperature, ambient pressure, and fully saturated with water vapor (BTPS).
Echocardiography. Echocardiography and Doppler estimation of pressures were performed with a Philips SSD-800 echocardiograph (Philips Medical Systems, Bothell, WA). Mean pulmonary arterial pressure (Ppa) was estimated from pulmonary artery acceleration time, and systolic Ppa was estimated from the peak velocity of the tricuspid regurgitant jet, if present, by using the modified Bernoulli formula (36). Left ventricular diastolic function was assessed by comparing the initial peak transmitral velocity of early ventricular filling (E) and the late transmitral velocity of atrial contraction (A) and deriving the E/A ratio (38).
Clinical data. Pulse, blood pressure, temperature, and oxygen saturation (Nellcor N20P pulse oximeter. Nellcor-Puritan Bennet, Warwick, UK) were recorded on the morning of each measurement day. Acute mountain sickness (AMS) was assessed by use of the Lake Louise consensus scoring system (41).
Statistical analysis. Data are presented in text and tables as means ± SE. Normality was assessed by using the Shapiro-Wilks test. Serial measures were tested for statistical significance by using one-way ANOVA for repeated measures with significant post hoc differences being further analyzed by use of a Student-Newman-Keuls test for parametric data and a Dunnett's test for nonparametric data. Statistical significance was assumed at P < 0.05.
Because of the repeated nature of the measures, correlation analysis was performed by using the Poon test for the analysis of linear and mildly nonlinear relationships using pooled subject data from all altitudes (40). Analyses were performed by use of SigmaStat 2.0 software (Jandell, San Rafael, CA) and a program written with Microsoft Excel for the Poon test.| |
RESULTS |
|---|
|
|
|---|
NPD.
Data were obtained on 18 of the 20 subjects. One subject could not
tolerate the procedure because of repeated gagging, and in one subject
a stable trace was never obtained. NPD hyperpolarized on ascent to HA01
and remained hyperpolarized at HA02 (both P < 0.05 vs.
BL) before returning to BL values on HA05. The PD during infusion with amiloride hyperpolarized on ascent to HA but did not
reach statistical significance. The PD during perfusion with the
low-chloride solution containing isoprenaline hyperpolarized on ascent
to HA01 (P < 0.05 vs. BL). Neither the
amiloride-inhibitable proportion nor the stimulated chloride proportion
of the PD changed significantly on ascent to or during stay at altitude
compared with baseline (Fig. 1).
|
Electrical impedance tomography.
Satisfactory data were obtained on 18 of 20 subjects with data on two
subjects being rejected because of consistently poor-quality recordings. The standardized change in impedance between RV and TLC
fell on ascent to HA01 (P < 0.05) and then returned to
BL values on subsequent days (Fig. 2).
|
FVC.
Data were obtained on all subjects. FVC fell on ascent to HA01 compared
with BL (P < 0.05) and remained significantly reduced compared with BL throughout the stay at altitude and at RBL
(P < 0.05, Table 1).
|
Ppa. Mean Ppa was measurable in 17 subjects at BL and in all subjects at HA and RBL. Systolic Ppa was measurable in 15 subjects at BL and 16 and 18 subjects at HA and RBL, respectively. Both mean and systolic Ppa increased on ascent with maximum values at HA01 and HA02 (P < 0.01 vs. BL) and then fell at HA05 although remaining significantly higher than BL throughout the rest of the stay at altitude (P < 0.05 vs. BL). Mean Ppa returned to BL values at RBL, although systolic Ppa remained elevated. The E/A ratio fell on ascent to HA and remained reduced throughout the stay at HA and at RBL (P < 0.05 vs. BL). These results are summarized in Table 1.
Oxygen saturation and AMS score. Data were obtained on all subjects. Oxygen saturation fell on ascent to HA01, remained significantly reduced throughout the stay at altitude compared with BL (all altitudes P < 0.05), and then returned to BL values at RBL. Despite a statistically significant increase, AMS score values never exceeded the accepted value of 3 for clinically relevant AMS. These results are summarized in Table 1.
Relationship between EIT and FVC changes and changes in NPD and
Ppa.
There was a positive correlation for FVC and the standardized change in
EIT (R2 = 0.633, P < 0.001; see Fig. 3) and between the basal
nasal potential and both FVC and the standardized change in EIT
(R2 = 0.418 and 0.267 respectively, both
P < 0.001; see Fig. 4). There was no relationship between mean Ppa and FVC or the standardized change in EIT (R2 = 0.0046 and 0.0411, respectively) or systolic Ppa and FVC or the standardized change in EIT
(R2 = 0.00006 and 0.0108, respectively).
|
|
| |
DISCUSSION |
|---|
|
|
|---|
This work demonstrates a hyperpolarization in the NPD in normal subjects on ascent to high altitude, a simultaneous fall in FVC, and changes in EIT, which would be consistent with an increase in EVLW. In addition, these findings occurred in the absence of signs of AMS and at the relatively low altitude of 3,800 m.
A fall in FVC on ascent to high altitude has been consistently reported by a number of authors, and our data are in keeping with this (32). The most likely mechanism behind this fall is the presence of subclinical pulmonary edema, although other suggested etiologies include an increase in pulmonary blood volume or reduced respiratory muscle strength. To date there is no evidence to support a sufficient reduction in resting muscle strength at altitude to produce a reduction in FVC.
Despite this circumstantial evidence, the major problem in proving the presence of subclinical pulmonary edema has been the absence of an accurate measure of EVLW that can be used in the mountain environment. Clinical examination and chest radiography are insensitive to small increases in EVLW (31, 47). Magnetic resonance imaging is highly sensitive but of limited practical use at high altitude (10). The thermal dye double-indicator dilution technique remains one of the more accurate methods in intact humans and can determine small changes in EVLW, but it is highly invasive and would be difficult to perform in large numbers of subjects at altitude (42). Transthoracic electrical impedance measurement has been used at altitude (14, 43), but the results have been disappointing and changes in lung volume with ventilation and the lack of spatial resolution further complicate the interpretation of results (11).
The Sheffield Applied Potential Tomograph system was developed to overcome these problems; it provides a portable device that generates a two-dimensional image of the impedance changes occurring during ventilation in a transverse cut through the thorax and allows a region of interest to be delineated for analysis. The parenchyma of the right lower lobe was chosen to be analyzed because in the upright position it has the maximum volume change with ventilation without cardiac interference. There is good correlation between EVLW measured by EIT and the double-indicator dilution technique in ventilated patients with acute respiratory failure (25) and in an oleic acid animal model of the acute respiratory distress syndrome (7).
Possible factors that would confound the EIT results are changes in pulmonary blood volume and lung volumes. According to the model of Nopp et al. (37), an increase in pulmonary blood volume from 500 to 600 ml (i.e., by 20%) will cause a drop in resistivity of 7% at 50 kHz, whereas a 20% change in extracellular fluid will cause a 40% change in resistivity at 50 kHz. To take account of changes in lung volume, our results were normalized with reference to the FVC at that altitude. However, the raw, nonnormalized results showed a mean reduction in the change in impedance of 22%. For this to be caused by an increase in pulmonary blood volume would require an increase in blood volume of over 300 ml or 60%, and we therefore conclude that it is highly improbable that a change in blood volume explains the change in EIT seen in this study.
Evidence of the effects of acute exposure to hypoxia on RV and TLC suggests that both increase on initial exposure to altitude but return to baseline after around a month at altitude (12). An increase in RV or a fall in TLC could produce a fall in FVC, but as both these volumes increase they would tend to cancel each other out, making it unlikely that changes in lung volume are a sufficient explanation for the observed impedance changes. In addition, the rapidity with which the impedance changes return to normal compared with the much longer time course for the normalization of lung volumes argues against the impedance changes being due to changes in lung volumes. Finally, an increase in lung volume at high altitude might be expected to decrease, rather than increase, the amount of estimated EVLW by augmenting the air content, which would increase resistivity of the lung tissue.
Using EIT, we have demonstrated a marked fall in the normalized change in impedance between RV and TLC on ascent to 3,800 m, which would be consistent with an increase in EVLW. This fall in impedance shows a strong relationship with FVC, with the smallest changes in impedance being associated with the lowest FVCs, suggesting that an increase in EVLW may be responsible for the fall in FVC seen at high altitude. That FVC did not return to baseline levels during the high-altitude sojourn, whereas EIT did, does not exclude the possibility that the fall in FVC is due to increased EVLW but may simply reflect differing sensitivities to the presence of EVLW by EIT and FVC.
Two possible causes for a possible increase in EVLW were addressed by this study. The control of EVLW has conventionally been attributed to the balance between Starling forces causing extravasation of water from the pulmonary capillaries and the ability of the pulmonary lymphatics to clear this water (46). The most important variable that influences the development of clinical pulmonary edema is the pulmonary capillary pressure (Ppc). In an invasive hemodynamic study at 4,559 m in the Swiss Alps, Maggiorini et al. (28) found a cutoff Ppc of 19 Torr for the development of HAPE in a group of HAPE-susceptible subjects. All subjects who developed HAPE had a Ppc >19 Torr, which corresponded to a mean Ppa > 35 Torr. No HAPE-susceptible subject who developed HAPE had a mean Ppa < 35 Torr.
We chose to use Doppler echocardiography to assess Ppa because it is
noninvasive and has been shown to correlate well with the results
obtained with right heart catheterization at high altitude
(1). None of our subjects' mean Ppa approached the cutoff
point of 35 mmHg observed by Maggiorini (maximum mean Ppa 20.2 ± 0.9 on HA1 of our study) excluding HAPE as a cause of any changes in
EVLW in this study. However, if subclinical pulmonary edema is of
hydrostatic origin, it is likely to occur at much lower Ppas than those
seen in clinical HAPE. Hargreaves et al. (13) demonstrated
increased activity in rabbit airway rapidly adapting receptors
suggestive of a physiological effect from interstitial edema after an
increase in left atrial pressure of as little as 5 mmHg. In keeping
with the findings of Boussuges et al. (3), we also found
alterations in transmitral flow on echo-Doppler with a decrease in the
E/A ratio on ascent to high altitude, suggestive of a reduction in left
ventricular diastolic compliance. A fall in diastolic compliance would
increase the risk of developing pulmonary edema on exercise
(45), and one may argue that some of the increase in EVLW
seen in this study could be due to repeatedly elevated Ppc during
physical activity. Nevertheless, the failure of the Poon analysis to
demonstrate any relationship between either mean or systolic Ppa and
either the changes in EIT or FVC, while demonstrating a strong
relationship between the changes in EIT or FVC and NPD, argues against
the subclinical pulmonary edema seen in this study being of
predominantly hydrostatic origin. This is also consistent with the work
of Sartori et al. (44), in which inhaled
2-agonists, known to increase transepithelial sodium
transport, decreased pulmonary edema in HAPE-susceptible individuals
without any effect on pulmonary hemodynamics.
During the last decade, it has become apparent that an intact alveolar
epithelium is necessary for the resolution of pulmonary edema
(35) and that uptake of water across the
alveolar-capillary barrier is an active process dependent on
transepithelial sodium transport. The sodium current is generated by
the basolateral Na-K-ATPase pump, and sodium enters the epithelium
through the apical ENaC, the rate-limiting step of this process
(34). In patients with acute lung injury and the acute
respiratory distress syndrome, reduced alveolar water clearance is
associated with increased morbidity and mortality (48),
whereas homozygote knockout mice born lacking the
-subunit of ENaC
died within 40 h of birth from pulmonary edema (15).
A number of factors may influence the sodium current, and thus water
uptake across the alveolar epithelium, including
-adrenergic
agonists, glucocorticoids, thyroid hormones, insulin, and certain
growth factors (34). Studies of cultured respiratory
epithelium suggest that hypoxia inhibits both the activity and
expression of both ENaC and the Na-K-ATPase pump
(29).
It is not possible to measure alveolar epithelial sodium transport in vivo in the human subject, but measurement of the PD generated by ion transport across the respiratory mucosa under the inferior turbinate of the nose can be used as a surrogate measure for ion transport in the distal respiratory epithelium tract and is a simple and well-tolerated measure to perform (21-23). Measurement of this NPD correlates well with the pathological changes seen in the airways of patients with cystic fibrosis (24). In a study of HAPE-susceptible individuals, Sartori et al. (44) found that their NPD at sea level was 32% less negative than in non-HAPE-susceptible subjects and that, in addition, superperfusion with amiloride produced a significantly smaller depolarization in NPD in the HAPE-susceptible compared with the HAPE-resistant subjects. This work was extended by Mairbäurl et al. (30), who confirmed a less negative NPD in HAPE-susceptible individuals, compared with nonsusceptible controls at low altitude, and stimulated chloride transport with a chloride-free solution containing amiloride and isoprenaline. Although there was no difference between susceptible or resistant subjects at low altitude, ascent to 4,559 m produced a large hyperpolarization in NPD, which was most marked in the nonsusceptible group, in whom it was due to a twofold increase in stimulated chloride secretion whereas sodium absorption was inhibited.
Our results differ from those of Mairbäurl et al. (30) in a number of ways. Although our baseline potentials were only slightly lower, ascent to 3,800 m did not produce such a large hyperpolarization in NPD, nor did we see any reduction in the amiloride-dependent sodium transport or a significant increase in isoprenaline-stimulated chloride transport at altitude. Our study took place at an altitude 750 m lower than that of Mairbäurl et al. and our subjects had almost no AMS. A prevalence of AMS of 53% has been reported at the Margharita hut used by Mairbäurl et al. for the high-altitude part of their study (27). Either the lower altitude with the resultant higher partial pressure of oxygen or the lower incidence of AMS might be responsible for the difference between our results. In addition, the study of Mairbäurl et al. was on white Caucasians, whereas the subjects in the present study were Altai-subtype Mongolians. Ireson et al. (17) have demonstrated a significant difference in NPD between blacks and whites, but little is known about other racial differences in NPD or respiratory epithelial ion transport. It is possible that differences between our results and those of Mairbäurl may in part be explained by racial differences.
The hyperpolarization in NPD on ascent to high altitude could be due either to changes in ion currents or to a change in transepithelial resistance. There is little information available on the changes in transepithelial resistance in hypoxia, and that which is available comes from work in cell monolayers. Mairbaurl et al. (29) demonstrated both small increases and decreases in the transepithelial resistance of rat type II pneumocytes exposed to different levels of hypoxia for between 4 and 24 h. However, in all cases the transepithelial PD fell, equivalent to a depolarization in vivo. From cellular work we can find no evidence to support an increase in transepithelial resistance as a cause for our findings.
Changes in ion currents could be due to either increased cation
absorption or increased anion secretion. The exact nature of cation
channels in the alveolar epithelium has been debated because of the
differing biophysical properties of channels encountered in cultured
cells. However, Jain and colleagues (18) demonstrated that
the culture conditions under which type II pneumocytes are grown
influence their biophysical properties. When ATII cells were grown on
glass plates submerged in media, the predominant channel was a 21-pS
nonselective cation channel. If they were grown on a permeable support
and in the presence of steroids and an air interface, the predominant
channel was a low-conductance (6.6 ± 3.4 pS), highly
Na+-selective channel, inhibited by submicromolar
concentrations of amiloride, and similar in biophysical properties to
ENaC. It now seems that the variety of different cation channels seen
in alveolar epithelium in part stems from the assembly of different combinations of the
-,
-, and
-subunits of ENaC with the
highly selective 4- to 6-pS channel containing all three of the
subunits (33). The absence of any change in the proportion
of the NPD inhibited by amiloride on ascent to altitude excludes this
being due to increased sodium absorption via an amiloride-sensitive ENaC and suggests that it could be all or partly explained by an
increase in sodium absorption via amiloride-insensitive nonspecific cation channels.
If the hyperpolarization is not due to increased cation absorption then
it must be due to increased anion secretion. Both chloride and
bicarbonate channels have been reported in rat fetal distal lung
epithelium (26), although only chloride channels have to
date been found in adult rat epithelium (20). Anion secretion would be associated with the secretion of water into the
luminal space. This is the normal state in the fetus (39). Chloride transport takes place by a number of apical channels, the
major ones being the cystic fibrosis transmembrane regulator (CFTR),
the outwardly rectifying chloride channel, and the calcium-activated chloride channel (19). Sympathomimetic agents such as
isoprenaline may activate CFTR (16). Such activation in
the presence of a favorable chemical gradient will stimulate apical
chloride secretion, estimating the transepithelial chloride transport
capacity of CFTR. The fact that stimulation of CFTR with isoprenaline
and a low-chloride solution showed no statistically significant
increase at high altitude in the present study only allows us to
conclude that CFTR Cl
transport was already maximally
stimulated by the low-chloride isoprenaline solution at sea level and
was not further stimulated by the increased levels of sympathetic
activity that occur at altitude. This does not exclude an alteration in
chloride transport via a channel other than CFTR or exclude bicarbonate secretion.
Although emphasizing that the presence of a correlation does not prove causality, the relationship demonstrated between NPD and both FVC and the change in EIT (Fig. 4) would argue in favor of anion secretion over sodium reabsorption as the cause for the hyperpolarization in NPD. The most negative PDs were associated with the lowest FVCs and the lowest changes in EIT between RV and TLC. Both a fall in FVC and a reduced increase in impedance on inspiration would be consistent with an increase in EVLW, a situation more compatible with increased anion secretion than sodium reabsorption.
In conclusion, this work demonstrates a hyperpolarization of the NPD in asymptomatic individuals on ascent to 3,800 m and simultaneous changes in EIT and FVC that may be consistent with an increase in EVLW. The changes in NPD suggest either an increase in sodium absorption via an amiloride-resistant cation pathway, either bicarbonate secretion or chloride secretion via a non-CFTR channel, or a combination of both mechanisms. Predominance of anion secretion over sodium reabsorption, if present in the alveoli, would be associated with the secretion of water into the lumen as occurs in the fetal lung (44). Further work is required to confirm the precise nature of these changes.
| |
ACKNOWLEDGEMENTS |
|---|
We express gratitude to the members of the Kyrgyz Presidential Guard who participated in this study; the staff of Kumtor Gold Mine, Kyrgyzstan, and in particular Dr. Francois du Toit, without whose help the project would not have been realized; Dr. Renaud Beauwens of the Department of Physiology of the Free University of Brussels for advice in the preparation of the manuscript; and Dr. Heimo Mairbäurl of the Department of Sports Physiology, University of Heidelberg for teaching the nasal potential technique.
This work was supported by Grant no. 3.4567.00 of the Fonds de la Recherche Scientifique Médical of Belgium.
| |
FOOTNOTES |
|---|
Address for reprint requests and other correspondence: N. Mason, Université Libre de Bruxelles, Laboratoire de Physiologie et de Physiopathologie, Faculté de Médecine-Campus Erasme, Bat. E2, niveau 4, Route de Lennik 808 - CP604, B-1070 Bruxelles, Belgium (E-mail: nmason{at}ulb.ac.be).
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
First published December 6, 2002;10.1152/japplphysiol.00777.2002
Received 26 August 2002; accepted in final form 20 November 2002.
| |
REFERENCES |
|---|
|
|
|---|
1.
Allemann, Y,
Sartori C,
Lepori M,
Pierre S,
Melot C,
Naeije R,
Scherrer U,
and
Maggiorini M.
Echocardiographic and invasive measurements of pulmonary artery pressure correlate closely at high altitude.
Am J Physiol Heart Circ Physiol
279:
H2013-H2016,
2000
2.
Barry, PH,
and
Lynch JW.
Liquid junction potentials and small cell effects in patch clamp analysis.
J Membr Biol
121:
101-117,
1991[ISI][Medline].
3.
Boussuges, A,
Molenat F,
Burnet H,
Cauchy E,
Gardette B,
Sainty JM,
Jammes Y,
and
Richalet JP.
Operation Everest III (Comex '97): modifications of cardiac function secondary to altitude-induced hypoxia. An echocardiographic and Doppler study.
Am J Respir Crit Care Med
161:
264-270,
2000
4.
British Thoracic Society and the Association of Respiratory Technicians and Physiologists.
Guidelines for the measurement of respiratory function.
Respir Med
88:
165-194,
1994[ISI][Medline].
5.
Brown, BH,
Barber DC,
Wang W,
Lu L,
Leathard AD,
Smallwood RH,
Hampshire AR,
Mackay R,
and
Hatzigalanis K.
Multi-frequency imaging and modelling of respiratory related electrical impedance changes.
Physiol Meas
15:
1-12,
1994[ISI][Medline], Suppl 2a.
6.
Brown, BH,
Flewelling R,
Griffiths H,
Harris ND,
Leathard AD,
Lu L,
Morice AH,
Neufeld GR,
Nopp P,
and
Wang W.
EITS changes following oleic acid induced lung water.
Physiol Meas
17:
117-130,
1996.
7.
Campbell, JH,
Harris ND,
Zhang F,
Morice AH,
and
Brown BH.
Detection of changes in intrathoracic fluid in man using electrical impedance tomography.
Clin Sci (Lond)
87:
97-101,
1994[Medline].
8.
Clerici, C,
and
Matthay MA.
Hypoxia regulates gene expression of alveolar epithelial transport proteins.
J Appl Physiol
88:
1890-1896,
2000
9.
Cremona, G,
Asnaghi R,
Baderna P,
Brunetto A,
Brutsaert T,
Cavallaro C,
Clark TM,
Cogo A,
Donis R,
Lanfranchi P,
Luks A,
Novello N,
Panzetta S,
Perini L,
Putnam M,
Spagnolatti L,
Wagner H,
and
Wagner PD.
Pulmonary extravascular fluid accumulation in recreational climbers: a prospective study.
Lancet
359:
303-309,
2002[ISI][Medline].
10.
Cutillo, AG,
Morris AH,
Ailon DC,
Case TA,
Durney CH,
Ganesan K,
Watanabe F,
and
Akhtari M.
Assessment of lung water distribution by nuclear magnetic resonance.
Am Rev Respir Dis
137:
1371-1375,
1984.
11.
Fein, A,
Grossman RF,
Jones JG,
Goodman PC,
and
Murray JF.
Evaluation of transthoracic electrical impedance in the diagnosis of pulmonary edema.
Circulation
60:
1156-1160,
1979
12.
Gaultier, C,
and
Crapo R.
Effects of nutrition, growth hormone disturbances, training, altitude and sleep on lung volumes.
Eur Respir J
10:
2913-2919,
1997[ISI][Medline].
13.
Hargreaves, M,
Ravi K,
and
Kappagoda CT.
Responses of slowly and rapidly adapting receptors in the airways of rabbits to changes in the Starling forces.
J Physiol
432:
81-97,
1991
14.
Hoon, RS,
Balasubramanian V,
Tiwari SC,
Mathew OP,
Behl A,
Sharma SC,
and
Chadha KS.
Changes in transthoracic electrical impedance at high altitude.
Br Heart J
39:
61-66,
1977
15.
Hummler, E,
Barker P,
Gatzy J,
Beermann F,
Verdumo C,
Schmidt A,
Boucher R,
and
Rossier BC.
Early death due to defective neonatal lung liquid clearance in alpha-ENaC-deficient mice.
Nat Genet
12:
325-328,
1996[ISI][Medline].
16.
Hwang, TC,
and
Sheppard DN.
Molecular pharmacology of the CFTR Cl
channel.
Trends Pharmacol Sci
20:
448-453,
1999[Medline].
17.
Ireson, NJ,
Tait JS,
MacGregor GA,
and
Baker EH.
Comparison of nasal pH values in black and white individuals with normal and high blood pressure.
Clin Sci (Colch)
100:
327-333,
2001[Medline].
18.
Jain, L,
Chen XJ,
Ramosevac S,
Brown LA,
and
Eaton DC.
Expression of highly selective sodium channels in alveolar type II cells is determined by culture conditions.
Am J Physiol Lung Cell Mol Physiol
280:
L646-L658,
2001
19.
Jentsch, TJ,
Stein V,
Weinreich F,
and
Zdebik AA.
Molecular structure and physiological function of chloride channels.
Physiol Rev
82:
503-568,
2002
20.
Jiang, X,
Ingbar DH,
and
O'Grady SM.
Adrenergic regulation of ion transport across adult alveolar epithelial cells: effects on Cl
channel activation and transport function in cultures with an apical air interface.
J Membr Biol
181:
195-204,
2001[ISI][Medline].
21.
Kersting, U,
Schwab A,
and
Hebestreit A.
Measurement of human nasal potential difference to teach the theory of transepithelial fluid transport.
Adv Physiol Educ
275:
S72-S77,
1998
22.
Knowles, MR,
Buntin WH,
Bromberg PA,
Gatzy JT,
and
Boucher RC.
Measurements of transepithelial electric potential differences in the trachea and bronchi of human subjects in vivo.
Am Rev Respir Dis
12:
108-112,
1982.
23.
Knowles, MR,
Carson JL,
Collier AM,
Gatzy JT,
and
Boucher RC.
Measurements of nasal transepithelial electric potential differences in normal human subjects in vivo.
Am Rev Respir Dis
124:
484-490,
1981[ISI][Medline].
24.
Knowles, M,
Gatzy J,
and
Boucher R.
Increased bioelectric potential difference across respiratory epithelia in cystic fibrosis.
N Engl J Med
305:
1489-1495,
1981[Abstract].
25.
Kunst, PW,
Vonk Noordegraaf AV,
Raaijmakers E,
Bakker J,
Groeneveld AB,
Postmus PE,
and
de Vries PM.
Electrical impedance tomography in the assessment of extravascular lung water in noncardiogenic acute respiratory failure.
Chest
116:
1695-1702,
1999
26.
Lazrak, A,
Thome U,
Myles C,
Ware J,
Chen L,
Venglarik CJ,
and
Matalon S.
cAMP regulation of Cl
and HCO
27.
Maggiorini, M,
Buhler B,
Walter M,
and
Oelz O.
Prevalence of acute mountain sickness in the Swiss Alps.
Br Med J
301:
853-855,
1990.
28.
Maggiorini, M,
Melot C,
Pierre S,
Pfeiffer F,
Greve I,
Sartori C,
Lepori M,
Hauser M,
Scherrer U,
and
Naeije R.
High-altitude pulmonary edema is initially caused by an increase in capillary pressure.
Circulation
103:
2078-2083,
2001
29.
Mairbaurl, H,
Mayer K,
Kim KJ,
Borok Z,
Bartsch P,
and
Crandall ED.
Hypoxia decreases active Na transport across primary rat alveolar epithelial cell monolayers.
Am J Physiol Lung Cell Mol Physiol
282:
L659-L665,
2002
30.
Mairbäurl, H,
Weymann J,
Möhrlein A,
Swenson E,
Maggiorini M,
Gibbs S,
and
Bärtsch P.
Decreased Na but increased Cl transport across the nasal epithelium in high altitude hypoxia (Abstract).
High Alt Med Biol
2:
A81,
2001.
31.
Marantz, PR,
Tobin JN,
Wassertheil-Smoller S,
Steingart RM,
Wexler JP,
Budner N,
Lense L,
and
Wachspress J.
The relationship between left ventricular systolic function and congestive heart failure diagnosed by clinical criteria.
Circulation
77:
607-612,
1988
32.
Mason, NP,
Barry PW,
Pollard AJ,
Collier DJ,
Taub NA,
Miller MR,
and
Milledge JS.
Serial changes in spirometry during an ascent to 5,300 m in the Nepalese Himalayas.
High Alt Med Biol
1:
185-195,
2000[Medline].
33.
Matalon, S,
Lazrak A,
Jain L,
and
Eaton DC.
Biophysical properties of sodium channels in lung alveolar epithelial cells.
J Appl Physiol
93:
1852-1859,
2002
34.
Matalon, S,
and
O'Brodovich H.
Sodium channels in alveolar epithelial cells: molecular characterization, biophysical properties, and physiological significance.
Annu Rev Physiol
61:
627-661,
1999[ISI][Medline].
35.
Matthay, MA,
and
Wiener-Kronish JP.
Intact epithelial barrier function is critical for the resolution of alveolar edema in humans.
Am Rev Respir Dis
142:
1250-1257,
1990[ISI][Medline].
36.
Naeije, R,
and
Torbicki A.
More on the noninvasive diagnosis of pulmonary hypertension: Doppler echocardiography revisited.
Eur Respir J
8:
1445-1449,
1995[ISI][Medline].
37.
Nopp, P,
Harris ND,
Zhao TX,
and
Brown BH.
Model for the dielectric properties of human lung tissue against frequency and air content.
Med Biol Eng Comput
35:
695-702,
1997[ISI][Medline].
38.
Oh, JK,
Appleton CP,
Hatle LK,
Nishimura RA,
Seward JB,
and
Tajik AJ.
The noninvasive assessment of left ventricular diastolic function with two-dimensional and Doppler echocardiography.
J Am Soc Echocardiogr
10:
246-270,
1997[ISI][Medline].
39.
Pitkanen, OM,
and
O'Brodovich HM.
Significance of ion transport during lung development and in respiratory disease of the newborn.
Ann Med
30:
134-142,
1998[ISI][Medline].
40.
Poon, CS.
Analysis of linear and mildly nonlinear relationships using pooled subject data.
J Appl Physiol
64:
854-859,
1988
41.
Roach, RC,
Bärtsch P,
Hackett PH,
and
Oelz O.
The Lake Louise acute mountain sickness scoring system.
In: Hypoxia and Mountain Medicine, edited by Sutton JR,
Houston CS,
and Coates G.. Burlington, VT: Queen City, 1993, p. 327-330.
42.
Rocker, GM.
Bedside measurement of pulmonary capillary permeability in patients with acute lung injury. What have we learned?
Intensive Care Med
22:
619-621,
1996[ISI][Medline].
43.
Roy, SB,
Balasubramanian V,
Khan MR,
Kaushik VS,
Manchanda SC,
and
Guha SK.
Transthoracic electrical impedance in cases of high-altitude hypoxia.
Br Med J
3:
771-775,
1974[ISI][Medline].
44.
Sartori, C,
Allemann Y,
Duplain H,
Lepori M,
Egli M,
Lipp E,
Hutter D,
Turini P,
Hugli O,
Cook S,
Nicod P,
and
Scherrer U.
Salmeterol for the prevention of high-altitude pulmonary edema.
N Engl J Med
346:
1631-1636,
2002
45.
Schwammenthal, E,
Vered Z,
Agranat O,
Kaplinsky E,
Rabinowitz B,
and
Feinberg MS.
Impact of atrioventricular compliance on pulmonary artery pressure in mitral stenosis: an exercise echocardiographic study.
Circulation
102:
2378-2384,
2000
46.
Staub, NC.
Pulmonary edema.
Physiol Rev
54:
678-811,
1974
47.
Vock, P,
Fretz C,
Franciolli M,
and
Bartsch P.
High-altitude pulmonary edema: findings at high-altitude chest radiography and physical examination.
Radiology
170:
661-666,
1989
48.
Ware, LB,
and
Matthay MA.
Alveolar fluid clearance is impaired in the majority of patients with acute lung injury and the acute respiratory distress syndrome.
Am J Respir Crit Care Med
163:
1376-1383,
2001
This article has been cited by other articles:
![]() |
S. M. Rowe, F. Accurso, and J. P. Clancy Detection of Cystic Fibrosis Transmembrane Conductance Regulator Activity in Early-Phase Clinical Trials Proceedings of the ATS, August 1, 2007; 4(4): 387 - 398. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Bernheim, S. Kiencke, M. Fischler, L. Dorschner, J. Debrunner, H. Mairbaurl, M. Maggiorini, and H. P. Brunner-La Rocca Acute Changes in Pulmonary Artery Pressures Due to Exercise and Exposure to High Altitude Do Not Cause Left Ventricular Diastolic Dysfunction Chest, August 1, 2007; 132(2): 380 - 387. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Luks and E. R. Swenson Travel to high altitude with pre-existing lung disease Eur. Respir. J., April 1, 2007; 29(4): 770 - 792. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Luks and E. R. Swenson Comet Tails in High-Altitude Pulmonary Edema: Diagnostic Portent or Streak in the Sky? Chest, April 1, 2007; 131(4): 951 - 953. [Full Text] [PDF] |
||||
![]() |
P. J. Fagenholz, J. A. Gutman, A. F. Murray, V. E. Noble, S. H. Thomas, and N. S. Harris Chest Ultrasonography for the Diagnosis and Monitoring of High-Altitude Pulmonary Edema Chest, April 1, 2007; 131(4): 1013 - 1018. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Mairbaurl, N. Mason, and P. Bartsch Nasal potentials at high altitude Eur. Respir. J., February 1, 2005; 25(2): 394 - 395. [Full Text] [PDF] |
||||
![]() |
C. Sartori, H. Duplain, M. Lepori, M. Egli, M. Maggiorini, P. Nicod, and U. Scherrer High altitude impairs nasal transepithelial sodium transport in HAPE-prone subjects Eur. Respir. J., June 1, 2004; 23(6): 916 - 920. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Mairbaurl, F. Schwobel, S. Hoschele, M. Maggiorini, S. Gibbs, E. R. Swenson, and P. Bartsch Altered ion transporter expression in bronchial epithelium in mountaineers with high-altitude pulmonary edema J Appl Physiol, November 1, 2003; 95(5): 1843 - 1850. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |